EFG Asset Management (Americas)’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-994
Closed -$324K 139
2024
Q1
$324K Sell
994
-481
-33% -$118K 0.1% 112
2023
Q4
$281K Buy
1,475
+31
+2% +$5.86K 0.06% 130
2023
Q3
$288K Buy
1,444
+61
+4% +$14.4K 0.07% 128
2023
Q2
$395K Sell
1,383
-130
-9% -$36.1K 0.09% 116
2023
Q1
$328K Buy
1,513
+318
+27% +$62K 0.08% 121
2022
Q4
$246K Buy
1,195
+42
+4% +$10.6K 0.06% 122
2022
Q3
$321K Sell
1,153
-103
-8% -$26.2K 0.08% 113
2022
Q2
$240K Buy
1,256
+88
+8% +$15.5K 0.06% 123
2022
Q1
$242K Buy
+1,168
New +$193K 0.04% 129

Other funds holding SWAV

EFG Asset Management (Americas)'s SWAV Position: Q2 2024 in Review

EFG Asset Management (Americas) sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 994 shares — an estimated $324K sold.

EFG Asset Management (Americas) first reported a position in SWAV in Q1 2022 and held it in 9 quarters. The position peaked at $395K in Q2 2023. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • EFG Asset Management (Americas) reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • EFG Asset Management (Americas) sold 994 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $324K.
  • EFG Asset Management (Americas) first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2022 and held it in 9 quarters.
  • EFG Asset Management (Americas)'s Shockwave Medical, Inc. Common Stock position peaked at $395K in Q2 2023.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on EFG Asset Management (Americas)'s 13F filing for Q2 2024, filed 6 Aug 2024.